Literature DB >> 6321733

Cardiac glycosides. 1. A systematic study of digitoxigenin D-glycosides.

D S Fullerton, M Kihara, T Deffo, E Kitatsuji, K Ahmed, B Simat, A H From, D C Rohrer.   

Abstract

A series of digitoxigenin glycosides was studied: five with beta-D-sugars varying stepwise in sugar structure from beta-D-digitoxose to beta-D-galactose, including one beta-D/alpha-D pair. I50 values for these glycosides and digitoxigenin were determined with hog kidney Na+, K+-ATPase. These data suggest a major and unexpected role for 4'-OH conformation in the sugar. All the glycosides with an equatorial 4'-OH were more active than the two with the 4'-OH axial [digitoxigenin beta-D-galactoside (6) I50 = 6.45 X 10(-8) M; digitoxigenin 2'-deoxy-alpha-D-ribo-hexopyranoside (alpha-3a) I50 = 9.33 X 10(-8) M; digitoxigenin I50 = 1.17 X 10(-7) M]. Stereochemistry of the 3'-OH had much less of an activity role than that of the 4'-OH, in contrast to existing models of "sugar-site" binding.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321733     DOI: 10.1021/jm00369a004

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Stereochemical survey of digitoxin monosaccharides: new anticancer analogues with enhanced apoptotic activity and growth inhibitory effect on human non-small cell lung cancer cell.

Authors:  Hua-Yu Leo Wang; Wenjun Xin; Maoquan Zhou; Todd A Stueckle; Yon Rojanasakul; George A O'Doherty
Journal:  ACS Med Chem Lett       Date:  2011-01-13       Impact factor: 4.345

2.  Digitalis receptor sugar binding site characteristics: a model based upon studies of Na+, K(+)-ATPase preparations with differing digitalis sensitivities.

Authors:  A H From; D S Fullerton; K Ahmed
Journal:  Mol Cell Biochem       Date:  1990-05-10       Impact factor: 3.396

3.  Cardiac glycosides with non-rotating steroid to sugar linkages: tools for the study of digitalis structure-activity relationships.

Authors:  L Brown; R Thomas; T Watson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

4.  The lead structure in cardiac glycosides is 5 beta, 14 beta-androstane-3 beta 14-diol.

Authors:  W Schönfeld; J Weiland; C Lindig; M Masnyk; M M Kabat; A Kurek; J Wicha; K R Repke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-06       Impact factor: 3.000

5.  Hellebrin and its aglycone form hellebrigenin display similar in vitro growth inhibitory effects in cancer cells and binding profiles to the alpha subunits of the Na+/K+-ATPase.

Authors:  Laetitia Moreno Y Banuls; Adriana Katz; Walter Miklos; Alessio Cimmino; Daniel M Tal; Elena Ainbinder; Martin Zehl; Ernst Urban; Antonio Evidente; Brigitte Kopp; Walter Berger; Olivier Feron; Steven Karlish; Robert Kiss
Journal:  Mol Cancer       Date:  2013-04-26       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.